Literature DB >> 19398674

Clopidogrel and the concept of high-risk pharmacokinetics.

Dan M Roden, C Michael Stein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19398674     DOI： 10.1161/CIRCULATIONAHA.109.865907

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  16 in total

Review 1.  Cardiovascular pharmacogenomics: current status and future directions.

Authors:  Dan M Roden
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

2.  [Clinical importance of the clopidogrel - omeprazole interaction: a question to solve].

Authors:  Pedro Amariles; Héctor Holguín; Mauricio Ceballos
Journal:  Aten Primaria       Date:  2011-08-31       Impact factor: 1.137

3.  Clopidogrel does not work following cardiopulmonary resuscitation.

Authors:  Thor W Bjelland; Oyvind Hjertner; Pål Klepstad; Kjell Kaisen; Ola Dale; Bjørn Olav Haugen
Journal:  Eur J Clin Pharmacol       Date:  2013-05-11       Impact factor: 2.953

Review 4.  Genetic determinants of response to cardiovascular drugs.

Authors:  Quinn S Wells; Jessica T Delaney; Dan M Roden
Journal:  Curr Opin Cardiol       Date:  2012-05       Impact factor: 2.161

Review 5.  Pharmacogenomics: will the promise be fulfilled?

Authors:  Russ B Altman; Heyo K Kroemer; Catherine A McCarty; Mark J Ratain; Dan Roden
Journal:  Nat Rev Genet       Date:  2010-11-30       Impact factor: 53.242

Review 6.  [Drug therapy for pain associated with osteoporotic fractures and subsequent conditions].

Authors:  N Müller
Journal:  Orthopade       Date:  2010-04       Impact factor: 1.087

Review 7.  Antithrombotics for secondary prevention of noncardioembolic ischaemic stroke.

Authors:  Bruce A Warden; Alana M Willman; Craig D Williams
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

8.  [Secondary prevention of stroke according to PRoFESS and SPARCL].

Authors:  D Sander; T Etgen
Journal:  Internist (Berl)       Date:  2009-11       Impact factor: 0.743

Review 9.  Pharmacogenetic profiling in the treatment of heart disease.

Authors:  Gerald W Dorn
Journal:  Transl Res       Date:  2009-08-12       Impact factor: 7.012

10.  Clopidogrel variability: role of plasma protein binding alterations.

Authors:  Shobana Ganesan; Craig Williams; Cheryl L Maslen; Ganesh Cherala
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.